Loading clinical trials...
Loading clinical trials...
The goal of this observational study is to explore the association of peptidoglycan fragments derived from gut microbiota with colorectal cancer (CRC). The main question it aims to answer is: Are peptidoglycan fragments from the gut microbiota associated with the progression of colorectal cancer? Participants will provide biological specimens (blood, feces, colon tissue obtained during surgery)
To explore whether peptidoglycan fragments can be used as screening or diagnostic indicators for colorectal cancer
Age
All ages
Sex
ALL
Healthy Volunteers
Yes
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China
Start Date
July 1, 2023
Primary Completion Date
December 1, 2024
Completion Date
December 1, 2024
Last Updated
April 26, 2024
200
ESTIMATED participants
observational study, no intervention
OTHER
Lead Sponsor
Zhujiang Hospital
NCT04704661
NCT06696768
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions